FDA NDC Directory · JSON-LD · Markdown

sucralfate

NDC 0378-9205 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA212913
Dosage form / routeSUSPENSION · ORAL
Active ingredientsSUCRALFATE (1 g/10mL)
Marketing started20220922
Package count1

External sources

Source: openFDA. Public-domain (CC0).